Headshot of Dr. Peter Bach

Dr. Peter Bach Endorses Delinkage for Orphan Drugs

At an October 21, 2016 Partnership for Quality Care drug pricing forum at the Kaiser Permanent Center for Total Health in Washington, D.C., Dr. Peter Bach, the Director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, endorsed the idea of delinkage in connection with his proposals on value-based pricing.┬áIn particular, Read more about Dr. Peter Bach Endorses Delinkage for Orphan Drugs[…]